Author

M. Yalon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Toren· 1 shared K. Eytan· 1 shared M. Leitner· 1 shared S. Paglin· 1 shared Z. Versano· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Toren

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 25, 2020

Pediatric glioblastoma - unlike normal cells - are sensitive to the combination of vorinostat and olaparib and to its downstream effector - phosphorylated eIF2α

K. Eytan, Z. Versano, M. Leitner…·M. Yalon

This study identifies that pediatric glioblastoma cells are sensitive to combinations of vorinostat and PARP-1 inhibitors, and to inhibitors of phosphorylated eIF2 dephosphorylation, with potential therapeutic implications.

DOI 10.1101/2020.11.25.397497

humanexperimental assay

𝕏 PostBluesky